A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.

Kharitonova T, Bragina T, Ivanova E, Savello A, Skoromets T, Petrikov S.

Open source

DOI
10.3389/fneur.2025.1683976
Published
2026-01-02
Container
Front Neurol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2025.1683976,
  title = {A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.},
  author = {Kharitonova T and  Bragina T and  Ivanova E and  Savello A and  Skoromets T and  Petrikov S.},
  year = {2025},
  journal = {Front Neurol},
  doi = {10.3389/fneur.2025.1683976},
  url = {https://doi.org/10.3389/fneur.2025.1683976}
}

RIS

TY  - JOUR
TI  - A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.
AU  - Kharitonova T
AU  -  Bragina T
AU  -  Ivanova E
AU  -  Savello A
AU  -  Skoromets T
AU  -  Petrikov S.
PY  - 2025
JO  - Front Neurol
DO  - 10.3389/fneur.2025.1683976
UR  - https://doi.org/10.3389/fneur.2025.1683976
ER  - 

APA

T, K., T, B., E, I., A, S., T, S., & S., P. (2025). A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.. Front Neurol. https://doi.org/10.3389/fneur.2025.1683976

Source records